UNSPSC 51111772: Vinorelbine

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C45H54N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q6C979R91Y, chemically known as c-norvincaleukoblastine, 3,4-didehydro-4-deoxy-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (salt) but generally known as vinorelbine, which bears US NIH Compound Identifier 60779. European Medicines Agency schedules Vinorelbine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00069MIG.

UNSPSC 51111772 Vinorelbine is a Commodity code that nominally designates a specific chemotherapy agent, but recent state and local procurement activity under this code does not reflect purchases of vinorelbine itself. Instead, the code appears to be used as a catch-all for pharmaceutical and medical supply procurement across a range of product categories—including naloxone, over-the-counter medications, generic multi-source pharmaceuticals, and emergency medical supplies. State and local health departments, municipal fire departments, and cooperative purchasing alliances issue opportunities under this code. The scope of work spans direct pharmaceutical procurement (generic drugs, OTC products), emergency response supplies (naloxone, first aid kits, respiratory equipment), and pharmacy benefit program management through direct-to-manufacturer models. Issuing bodies include county health systems, state HHS agencies, municipal fire and rescue divisions, and multistate cooperative purchasing entities. The code shows activity across health departments seeking to source medications and naloxone for community health initiatives, fire departments procuring medical and rescue supplies, and state pharmacy benefit programs exploring direct contracting with manufacturers to bypass traditional pharmacy benefit managers and group purchasing organizations.

Recent opportunities span Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with a response deadline of July 26, 2023. The City of Tampa's Purchasing Department posted IFB 26P00145 in March 2026 for medical and first aid supplies (169 line items including respiratory equipment, cardiac monitoring electrodes, and oxygen delivery systems) for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside with a 5 percent bid discount not to exceed $10,000. The Texas Health and Human Services Commission released an RFI (HHS0017013) in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking direct contracting arrangements between state agencies and pharmaceutical manufacturers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson) with pricing weighted 75 percent in evaluation and a 3 percent administrative fee required.